Skip to main content
. 2023 Nov 14;14(6):2898–2907. doi: 10.1002/jcsm.13367

Figure 1.

Figure 1

Flow diagram showing selection of the study population. PD‐1, programmed death receptor 1; PD‐L1, programmed death ligand 1; NSCLC, non‐small cell lung cancer.